{"entity":{"id":"boehringer-ingelheim-biox","kind":"company","name":"Boehringer Ingelheim BioXcellence","aka":[],"tldr":"Boehringer Ingelheim BioXcellence is the contract-manufacturing arm of Boehringer Ingelheim, one of the largest antibody producers by volume.","summary":"Boehringer Ingelheim BioXcellence, based in Ingelheim, is the contract manufacturing arm of Boehringer Ingelheim, one of the largest antibody producers by volume. It offers mammalian and microbial biologics manufacturing in Germany, Austria, China and the United States. OnCo links it to antibody manufacturing through CHO bioprocessing. Whether a pharmaceutical company can run a contract manufacturing business for competitors without conflicts over capacity is the fair question. The antibody manufacturing page carries the wider picture.","asOf":"2026-09-08","links":[{"label":"Official website","url":"https://www.boehringer-ingelheim.com/bioxcellence"}],"tags":["supporting"],"related":[],"cancers":[],"sections":["immunotherapy"],"technologies":["monoclonal-antibody-manufacturing"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Ingelheim","country":"DE","companyType":"cro-services","website":"https://www.boehringer-ingelheim.com/bioxcellence","investors":[],"funding":[]},"route":"/companies/boehringer-ingelheim-biox/","neighbours":{"section":[{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"}],"technology":[{"id":"monoclonal-antibody-manufacturing","kind":"technology","name":"Antibody manufacturing (CHO bioprocessing)","route":"/technologies/monoclonal-antibody-manufacturing/"},{"id":"downstream-purification-chromatography","kind":"technology","name":"Downstream purification (Protein A capture, viral clearance, polishing)","route":"/technologies/downstream-purification-chromatography/"}]}}